T 2730/16 of 07.12.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T273016.20201207
- Date of decision
- 7 December 2020
- Case number
- T 2730/16
- Petition for review of
- -
- Application number
- 07784499.1
- IPC class
- A61K 31/70A61P 3/10C07H 7/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTALLINE SOLVATES OF (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL) METHYL) PHENYL)-D-GLUCITOL DERIVATIVES WITH ALCOHOLS AS SGLT2 INHIBITORS FOR THE TREATMENT OF DIABETES
- Applicant name
- AstraZeneca AB
- Opponent name
- LEK Pharmaceuticals d.d.
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)
- Keywords
- Inventive step - (yes)
Reasonable expectation to solve objective technical problem (no) - Catchword
- -
Order
For these reasons it is decided that:
The appeal is dismissed.